Table 3.
Components or strategy | Preparation method | Route | Drug or purpose | Assessment format | Observations | Ref. |
---|---|---|---|---|---|---|
Self-assembled nano-colloidal polymeric micelles (LP-PMs) of Soluplus and PF127 | Thin-film hydration method | i.v. | Lapatinib | Haemolysis Platelet aggregation test |
The degree of hemolysis is within an acceptable range. No aggregation was observed in the control or LP-PM treated blood samples. | [76] |
Amphiphilic maltodextrin-ursodeoxycholic acid (FA and lactobionic acid were coupled to the surface of micelles) | Dialysis method | – | Sulfasalazine and resveratrol | Serum stability Haemolysis |
All the evaluated parameters are within the acceptable range. | [77] |
Redox-sensitive heparin-β-sitosterol | Probe sonication and aqueous dialysis | i.v. | Doxorubicin | Haemolysis | The preparation has no significant effect on red blood cells. | [78] |
A series of Chondroitin sulfate/poly (D,L-lactideco-glycolide) block copolymers (CHs-b-PLGA) with different length of hydrophobic block | Sonicate method | i.v. | Doxorubicin | Haemolysis | As the molecular weight of PLGA increases, the hemolysis rate of micelles increases slightly. However, the degree of hemolysis in all formulations is within an acceptable range. | [79] |
Amphiphilic bifunctional pullulan derivative | Dialysis method | i.v. | Doxorubicin | Haemolysis | The degree of hemolysis is within an acceptable range. | [80] |
Amphiphilic styrene-maleic acid (SMA) copolymer | Dialysis method | – | 3,4-Difluorobenzylidene curcumin (CDF) | Serum stability | SMA-CDF nanomicelles exposed to fibrinogen or 50% FBS did not find any significant difference in particle size up to 72 h. | [81] |
Poly(D-lactide), poly(L-lactide) and stereocomplex micelle | Nanoprecipitation method | i.v. | Doxorubicin | Serum stability Haemolysis |
In PBS buffered BSA solution (30.0 mg/ml), all loaded micelles showed excellent stability during the 72-h measurement. The degree of hemolysis is within an acceptable range. | [82] |
A copolymer composed of carboxybetaine methacrylate (CBMA) as hydrophilic segment and 2-(methacryloyloxy)ethyl lipoate (MAEL) as hydrophobic | Dialysis method | i.v. | Doxorubicin | Serum stability | No increase in the size of drug-loaded micelles was observed in 1 mg / mL PBS solution and 50% FBS at 37 °C. | [83] |